- Home
- BNR vs KPLT Comparison
BNR vs KPLT Comparison
Compare BNR & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- KPLT
- Stock Information
- Founded
- BNR 2014
- KPLT 2012
- Country
- BNR China
- KPLT United States
- Employees
- BNR N/A
- KPLT N/A
- Industry
- BNR Medical Specialities
- KPLT Diversified Commercial Services
- Sector
- BNR Health Care
- KPLT Consumer Discretionary
- Exchange
- BNR Nasdaq
- KPLT Nasdaq
- Market Cap
- BNR 30.9M
- KPLT 35.6M
- IPO Year
- BNR 2020
- KPLT N/A
- Fundamental
- Price
- BNR $2.94
- KPLT $7.56
- Analyst Decision
- BNR
- KPLT Hold
- Analyst Count
- BNR 0
- KPLT 2
- Target Price
- BNR N/A
- KPLT $12.00
- AVG Volume (30 Days)
- BNR 20.3K
- KPLT 45.7K
- Earning Date
- BNR 05-28-2025
- KPLT 05-14-2025
- Dividend Yield
- BNR N/A
- KPLT N/A
- EPS Growth
- BNR N/A
- KPLT N/A
- EPS
- BNR N/A
- KPLT N/A
- Revenue
- BNR $70,669,261.00
- KPLT $247,194,000.00
- Revenue This Year
- BNR $136.32
- KPLT $20.12
- Revenue Next Year
- BNR N/A
- KPLT $13.19
- P/E Ratio
- BNR N/A
- KPLT N/A
- Revenue Growth
- BNR N/A
- KPLT 11.56
- 52 Week Low
- BNR $2.62
- KPLT $5.08
- 52 Week High
- BNR $8.99
- KPLT $23.54
- Technical
- Relative Strength Index (RSI)
- BNR 24.38
- KPLT 36.30
- Support Level
- BNR $2.77
- KPLT $7.18
- Resistance Level
- BNR $3.29
- KPLT $9.28
- Average True Range (ATR)
- BNR 0.30
- KPLT 0.79
- MACD
- BNR 0.01
- KPLT -0.12
- Stochastic Oscillator
- BNR 13.82
- KPLT 17.03
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.